Healthcare

Patients Searching “Best Plastic Surgeon in America” Are Traveling for Clarity and Planning – Gruber Plastic Surgery Expands Out-of-Town Resources for 2026

Updated Fly-In Program outlines virtual consultations, travel timelines, recovery planning, and follow-up care for out-of-town patients visiting Tampa, Florida. TAMPA,...

Dr. Kunaal Jindal Sheds Light on His Signature Mommy Makeover, Which Includes his High Definition Tummy Tuck with Liposculpting and Breast Reshaping

A closer look at the artistry, technique, and philosophy behind Dr. Jindal's most sought-after transformation. TORONTO, ON / ACCESS Newswire...

Xtalks Life Science Podcast Wraps Up 2025 with Deep Dives into Drug Development, Regulation, Clinical Trials and Innovation, Sets Sights on a Transformative 2026 by Xtalks

In 2025, the Xtalks Life Science Podcast featured conversations with industry leaders across pharma, biotech, medtech and healthcare, highlighting innovations...

Peer-Reviewed Studies Validate Linus Health AI as an Early Digital Biomarker for Alzheimer’s Pathology, Helping People Take Action Earlier to Slow Disease Impact

Findings show Linus Health's AI can indicate Alzheimer's pathology before noticeable symptoms—enabling earlier action to help protect independence and preserve...

1933 Industries Issues Reminder to Debenture Holders Ahead of December 22 Conversion Deadline and Highlights Positive Industry Developments

VANCOUVER, BC / ACCESS Newswire / December 19, 2025 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTCID:TGIFF) is...

Profound Medical Corp. Announces Pricing of up to $40 Million Financing Comprised of a $36 Million Registered Direct Offering and a Subsequent $4 Million Private Placement

Financing included participation by healthcare-dedicated investors alongside existing shareholdersTORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (Nasdaq:PROF; TSX:PRN)...

Polyrizon Submits Pre-Request for Designation to FDA for PL-16 Viral Blocker Designed to Reduce the Exposure to Influenza and Cold Viruses

The PL-16 Viral Blocker has shown over 90% success in protection of cells against viruses Raanana, Israel, Dec. 19, 2025...

error: Content is protected !!